1 Department of Clinical Microbiology, Amager and Hvidovre Hospital, The Capital Region of Denmark2 Klinisk Mikrobiologisk Afdeling, Hvidovre Hospital3 Klinisk Mikrobiologisk Afdeling, Diagnostisk Center, Rigshospitalet, The Capital Region of Denmark4 unknown
The prevalence of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is increasing and the therapeutic options are limited, especially in primary care. Recent indications have suggested pivmecillinam to be a suitable option. Here, we evaluated the clinical and bacteriological effects of pivmecillinam in UTIs caused by ESBL-producing Enterobacteriaceae.
Journal of Antimicrobial Chemotherapy, 2014, Vol 69, Issue 3, p. 769-772